Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR.
She was most recently a correspondent at Kaiser Health News, where she covered drug prices and specialized in data reporting for its enterprise team. She's reported on how tainted drugs can reach consumers, how companies take advantage of rare disease drug rules and how FDA-approved generics often don't make it to market. She's also tracked pharmaceutical dollars to patient advocacy groups and members of Congress. Her work has won the National Press Club's Joan M. Friedenberg Online Journalism Award, the National Institute for Health Care Management's Digital Media Award and a health reporting award from the Society for Advancing Business Editing and Writing.
Lupkin graduated from Boston University. She's also worked for ABC News, VICE News, MedPage Today and The Bay Citizen. Her internship and part-time work includes stints at ProPublica, The Boston Globe, The Boston Herald, The New England Center for Investigative Reporting and WCVB.
-
The pharmaceutical industry has long said that any attempts to control drug prices would mean disaster for their research and development efforts. But the research doesn't back that up.
-
The government will negotiate new prices for the commonly prescribed drugs, but the cuts won't take effect until 2026. In the meantime, drugmakers are fighting the negotiations with lawsuits. -
The Food and Drug Administration has approved approve the first RSV vaccine that can be given during pregnancy to protect newborn babies.
-
The Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV. -
A tornado that ripped through a Pfizer plant in Rocky Mount, N.C., raised worries about shortages of medicines used in hospitals. The drugs include commonly used painkillers and anesthetics. -
A tornado that tore through a Pfizer factory in North Carolina could exacerbate drug shortages. Records obtained by NPR show the plant made dozens of products, including painkillers and anesthetics.
-
The arthritis drug Humira has been a blockbuster seller for more than two decades. Now, some copycats could end Humira's reign.
-
The arthritis drug Humira has been a blockbuster seller for more than two decades. Now some copycats could end Humira's reign.
-
The Food and Drug Administration has approved the first over-the-counter birth control pill. The daily oral contraceptive, called Opill, will be available without a prescription.
-
Children who need growth hormone to achieve their full stature are having trouble getting the medicine. A shortage has stretched months longer than expected and could last the rest of the year.
